Publication | Closed Access

Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications

Neurodegenerative DiseasesPharmaceutical SciencePolymer-drug ConjugateMedicineMultiple Therapeutic IndicationsClinical DevelopmentDrug Delivery SystemsVersatile Polymer PlatformPharmacotherapyDrug DevelopmentPharmacologyDrug Discovery